Comparison of efficacy and safety between TIcagrelor and clopidogrel in Chinese patients with acute coronary syndrome (COSTIC study)

Background: Ticagrelor is recommended as the preferred antiplatelet agent for patients with acute coronary syndrome (ACS), which is controversial in East Asians, Chinese patients in particular. This study aimed to compare the efficacy and safety of ticagrelor vs. clopidogrel in Chinese ACS patients...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Man Huang, Yang Sun, Ke Li, Ting Yu, Hu Zhao, Min Tao, Xiuli Song, Linlin Wang, Xin Xu, Yanghui Chen, Guanglin Cui, Hu Ding, Jiangtao Yan, Jiangang Jiang, Hesong Zeng, Yan Wang, Xiaoqing Shen, Hong Wang, Dao Wen Wang
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2026-02-01
Serie:	International Journal of Cardiology: Heart & Vasculature
Soggetti:	Ticagrelor Clopidogrel Acute coronary syndrome Percutaneous coronary intervention Clinical endpoints
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2352906726000023
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!